MARTINSRIED, Germany, Jan. 29, 2009 (GLOBE NEWSWIRE) -- MorphoSys AG (FSE: MOR) (Prime Standard Segment) announced today the appointment of a new Head of its AbD Serotec business for research and diagnostic antibodies. Dieter Feger joins MorphoSys from Abbott Diagnostics, Illinois, a global leader in in vitro diagnostics. For the last four years, he held the position of Marketing Director - Global Marketing, most recently with responsibility for Infectious Diseases, Abbott Diagnostics’ biggest reagent franchise. Prior to that, he spent 18 years with Abbott in Europe, in a variety of roles including sales, product management, operational management and marketing before moving to the U.S. He replaces Dieter Lingelbach who has left MorphoSys to pursue new opportunities.
